Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Langenbeck's Archives of Surgery
Erschienen in: Langenbeck's Archives of Surgery 3/2012

01.03.2012 | Review Article

The role of lateral lymph node dissection in the management of lower rectal cancer

verfasst von: Ziting Wang, Kep Yong Loh, Kok-Yang Tan, Emile Chung-Hou Woo

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Lateral lymph node involvement is a problem encountered in patients with low rectal cancers. This has been documented in both anatomical and pathological studies. Currently, the vast majority of centers have concentrated on the use of chemoradiation to obtain better local control and manage these nodes indirectly. In Japan, extended nodal dissection for the control of pelvic nodal disease has seen further advancement. This paper discusses the key issues involved in the management of pelvic lateral nodes in low rectal cancers.

Methods

A review of available literature and critical appraisal of the entity of lateral nodes in low rectal cancers, the treatment options, and oncological and functional results were performed.

Results

There are good data showing that the entity of pelvic lateral nodes in low rectal cancers should not be ignored. Recent data have emerged showing that radiotherapy is associated with significant long-term functional side effects. Refinement of the technique, lateral node dissection, has led to good local control as well as good functional outcomes.

Conclusion

In this context, there needs to be a reevaluation of the role of chemoradiation as the sole treatment for lateral nodal disease in centers outside of Japan. Individualization of the treatment of rectal cancer may require all centers to be able to offer both modalities.
Literatur
1.
Heald RJ, Moran BJ (1998) Embryology and anatomy of the rectum. Semin Surg Oncol 15(2):66–71PubMedCrossRef
2.
Funahashi K, Koike J, Shimada M, Okamoto K, Goto T, Teramoto T (2006) A preliminary study of the draining lymph node basin in advanced lower rectal cancer using a radioactive tracer. Dis Colon Rectum 49(10 Suppl):S53–58PubMedCrossRef
3.
Min BS, Kim JS, Kim NK, Lim JS, Lee KY, Cho CH, Sohn SK (2009) Extended lymph node dissection for rectal cancer with radiologically diagnosed extramesenteric lymph node metastasis. Ann Surg Oncol 16(12):3271–3278PubMedCrossRef
4.
Akasu T, Sugihara K, Moriya Y (2009) Male urinary and sexual functions after mesorectal excision alone or in combination with extended lateral pelvic lymph node dissection for rectal cancer. Ann Surg Oncol 16(10):2779–2786PubMedCrossRef
5.
Kim TH, Jeong SY, Choi DH, Kim DY, Jung KH, Moon SH, Chang HJ, Lim SB, Choi HS, Park JG (2008) Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 15(3):729–737PubMedCrossRef
6.
Ueno M, Oya M, Azekura K, Yamaguchi T, Muto T (2005) Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br J Surg 92(6):756–763PubMedCrossRef
7.
Takahashi T, Ueno M, Azekura K, Ohta H (2000) Lateral node dissection and total mesorectal excision for rectal cancer. Dis Colon Rectum 43(10 Suppl):S59–68PubMedCrossRef
8.
Yano H, Saito Y, Takeshita E, Miyake O, Ishizuka N (2007) Prediction of lateral pelvic node involvement in low rectal cancer by conventional computed tomography. Br J Surg 94(8):1014–1019PubMedCrossRef
9.
Sugihara K, Kobayashi H, Kato T, Mori T, Mochizuki H, Kameoka S, Shirouzu K, Muto T (2006) Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 49(11):1663–1672PubMedCrossRef
10.
Fujita S, Yamamoto S, Akasu T, Moriya Y (2009) Risk factors of lateral pelvic lymph node metastasis in advanced rectal cancer. Int J Colorectal Dis 24(9):1085–1090PubMedCrossRef
11.
Tan KY, Yamamoto S, Fujita S, Akasu T, Moriya Y (2010) Improving prediction of lateral node spread in low rectal cancers—multivariate analysis of clinicopathological factors in 1,046 cases. Langenbecks Arch Surg/Deutsche Gesellschaft fur Chirurgie 395(5):545–549
12.
Yano H, Moran BJ (2008) The incidence of lateral pelvic side-wall nodal involvement in low rectal cancer may be similar in Japan and the West. Br J Surg 95(1):33–49PubMedCrossRef
13.
Matsuoka H, Nakamura A, Masaki T, Sugiyama M, Nitatori T, Ohkura Y, Sakamoto A, Atomi Y (2007) Optimal diagnostic criteria for lateral pelvic lymph node metastasis in rectal carcinoma. Anticancer Res 27(5B):3529–3533PubMed
14.
Kim NK, Kim MJ, Park JK, Park SI, Min JS (2000) Preoperative staging of rectal cancer with MRI: accuracy and clinical usefulness. Ann Surg Oncol 7(10):732–737PubMedCrossRef
15.
Georgiou P, Tan E, Gouvas N, Antoniou A, Brown G, Nicholls RJ, Tekkis P (2009) Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol 10(11):1053–1062PubMedCrossRef
16.
Galandiuk S, Wieand HS, Moertel CG, Cha SS, Fitzgibbons RJ Jr, Pemberton JH, Wolff BG (1992) Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 174(1):27–32PubMed
17.
Regos J, Nagy L, Nagy Z, Morvay K (1990) Local recurrences following colorectal operations. Acta Chir Hung 31(2):117–124PubMed
18.
Lowry AC, Simmang CL, Boulos P, Farmer KC, Finan PJ, Hyman N, Killingback M, Lubowski DZ, Moore R, Penfold C, Savoca P, Stitz R, Tjandra JJ (2001) Consensus statement of definitions for anorectal physiology and rectal cancer: report of the Tripartite Consensus Conference on Definitions for Anorectal Physiology and Rectal Cancer, Washington, D.C., May 1, 1999. Dis Colon Rectum 44(7):915–919PubMedCrossRef
19.
Heald RJ, Husband EM, Ryall RD (1982) The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? Br J Surg 69(10):613–616PubMedCrossRef
20.
Ferenschild FT, Dawson I, de Wilt JH, de Graaf EJ, Groenendijk RP, Tetteroo GW (2009) Total mesorectal excision for rectal cancer in an unselected population: quality assessment in a low volume center. Int J Color Dis 24(8):923–929CrossRef
21.
Tentes AA, Korakianitis OS, Veliovic D, Sgouridou E, Karagiozoglou C, Moustakas K (2010) The impact of total mesorectal excision in middle and low rectal carcinomas. J Buon 15(1):56–60PubMed
22.
de Chaisemartin C, Penna C, Goere D, Benoist S, Beauchet A, Julie C, Nordlinger B (2009) Presentation and prognosis of local recurrence after total mesorectal excision. Colorectal Dis 11(1):60–66PubMedCrossRef
23.
Moriya Y, Hojo K, Sawada T, Koyama Y (1989) Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection. Dis Colon Rectum 32(4):307–315PubMedCrossRef
24.
Moriya Y, Sugihara K, Akasu T, Fujita S (1997) Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. World J Surg 21(7):728–732PubMedCrossRef
25.
Koch M, Kienle P, Antolovic D, Buchler MW, Weitz J (2005) Is the lateral lymph node compartment relevant? Recent results in cancer research. Fortschr Krebsforschung 165:40–45
26.
Syk E, Glimelius B, Nilsson PJ (2010) Factors influencing local failure in rectal cancer: analysis of 2315 patients from a population-based series. Dis Colon Rectum 53(5):744–752PubMedCrossRef
27.
Kusters M, Marijnen CA, van de Velde CJ, Rutten HJ, Lahaye MJ, Kim JH, Beets-Tan RG, Beets GL (2010) Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol 36(5):470–476PubMedCrossRef
28.
Swedish R, Cancer T (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 336(14):980–987CrossRef
29.
Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345(9):638–646PubMedCrossRef
30.
Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess C, Karstens J, Liersch T, Schmidberger H, Raab R (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351(17):1731–1740PubMedCrossRef
31.
Birgisson H, Pahlman L, Gunnarsson U, Glimelius B (2005) Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol 23(34):8697–8705PubMedCrossRef
32.
Birgisson H, Pahlman L, Gunnarsson U, Glimelius B (2007) Late adverse effects of radiation therapy for rectal cancer—a systematic overview. Acta Oncol (Stockholm, Sweden) 46(4):504–516CrossRef
33.
Birgisson H, Pahlman L, Gunnarsson U, Glimelius B (2008) Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy. Br J Surg 95(2):206–213PubMedCrossRef
34.
Marijnen CA, van de Velde CJ, Putter H, van den Brink M, Maas CP, Martijn H, Rutten HJ, Wiggers T, Kranenbarg EK, Leer JW, Stiggelbout AM (2005) Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 23(9):1847–1858PubMedCrossRef
35.
Braendengen M, Tveit KM, Bruheim K, Cvancarova M, Berglund A, Glimelius B (2010) Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized phase iii study. Int J Radiat Oncol Biol Phys. doi:10.​1016/​j.​ijrobp.​2010.​07.​007
36.
Frykholm GJ, Glimelius B, Pahlman L (1993) Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 36(6):564–572PubMedCrossRef
37.
Stephens RJ, Thompson LC, Quirke P, Steele R, Grieve R, Couture J, Griffiths GO, Sebag-Montefiore D (2010) Impact of short-course preoperative radiotherapy for rectal cancer on patients’ quality of life: data from the Medical Research Council CR07/National Cancer Institute of Canada Clinical Trials Group C016 randomized clinical trial. J Clin Oncol 28(27):4233–4239. doi:10.​1200/​JCO.​2009.​26.​5264 PubMedCrossRef
38.
39.
Moriya Y (2006) Function preservation in rectal cancer surgery. Int J Clin Oncol/Jpn Soc Clin Oncol 11(5):339–343CrossRef
40.
Kusters M, Beets GL, van de Velde CJ, Beets-Tan RG, Marijnen CA, Rutten HJ, Putter H, Moriya Y (2009) A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence. Ann Surg 249(2):229–235PubMedCrossRef
41.
Mann B (2004) Lateral lymph node dissection in rectal cancer patients: is there any indication? Int J Color Dis 19(3):195–196CrossRef
42.
Sato H, Maeda K, Maruta M (2011) Prognostic significance of lateral lymph node dissection in node positive low rectal carcinoma. Int J Color Dis 26(7):881–889CrossRef
43.
Matsuoka H, Masaki T, Sugiyama M, Atomi Y (2005) Impact of lateral pelvic lymph node dissection on evacuatory and urinary functions following low anterior resection for advanced rectal carcinoma. Langenbeck’s Arch Surg/DeSutsche Gesellschaft fur Chirurgie 390(6):517–522
44.
Hojo K, Vernava AM 3rd, Sugihara K, Katumata K (1991) Preservation of urine voiding and sexual function after rectal cancer surgery. Dis Colon Rectum 34(7):532–539PubMedCrossRef
45.
Moriya Y, Sugihara K, Akasu T, Fujita S (1995) Nerve-sparing surgery with lateral node dissection for advanced lower rectal cancer. Eur J Cancer 31A(7–8):1229–1232PubMedCrossRef
46.
Uyama I, Sugioka A, Matsui H, Fujita J, Komori Y, Hanai T, Hasumi A (2001) Laparoscopic lateral node dissection with autonomic nerve preservation for advanced lower rectal cancer. J Am Coll Surg 193(5):579–584PubMedCrossRef
47.
Kim JC, Takahashi K, Yu CS, Kim HC, Kim TW, Ryu MH, Kim JH, Mori T (2007) Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer. Ann Surg 246(5):754–762PubMedCrossRef
48.
Saito N, Sarashina H, Nunomura M, Koda K, Takiguchi N, Nakajima N (1998) Clinical evaluation of nerve-sparing surgery combined with preoperative radiotherapy in advanced rectal cancer patients. Am J Surg 175(4):277–282PubMedCrossRef
49.
Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK (1998) Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg 133(8):894–899PubMedCrossRef
50.
Bechtel J, Tepper J (2003) Adjuvant radiation therapy of patients with rectal cancer. Clin Colorectal Cancer 2(4):213–222PubMedCrossRef
51.
Wu ZY, Wan J, Li JH, Zhao G, Yao Y, Du JL, Liu QF, Peng L, Wang ZD, Huang ZM, Lin HH (2007) Prognostic value of lateral lymph node metastasis for advanced low rectal cancer. World J Gastroenterol 13(45):6048–6052PubMedCrossRef
52.
Arii K, Takifuji K, Yokoyama S, Matsuda K, Higashiguchi T, Tominaga T, Oku Y, Tani M, Yamaue H (2006) Preoperative evaluation of pelvic lateral lymph node of patients with lower rectal cancer: comparison study of MR imaging and CT in 53 patients. Langenbeck’s Arch Surg/Deutsche Gesellschaft fur Chirurgie 391(5):449–454
53.
Tada M, Endo M (1995) Ultrasonographic examination for lateral lymphatic spread and local recurrence of rectal cancer. Preoperative detection and evaluation. Dis Colon Rectum 38(10):1047–1052PubMedCrossRef
54.
55.
Shiozawa M, Akaike M, Yamada R, Godai T, Yamamoto N, Saito H, Sugimasa Y, Takemiya S, Rino Y, Imada T (2007) Lateral lymph node dissection for lower rectal cancer. Hepato-Gastroenterology 54(76):1066–1070PubMed
56.
57.
Marijnen CA, Nagtegaal ID, Kapiteijn E, Kranenbarg EK, Noordijk EM, van Krieken JH, van de Velde CJ, Leer JW (2003) Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 55(5):1311–1320PubMedCrossRef
58.
Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, Rutten H, Pahlman L, Glimelius B, Leer JW, van de Velde CJ (2007) The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246(5):693–701. doi:10.​1097/​01.​sla.​0000257358.​56863.​ce PubMedCrossRef
59.
Metadaten
Titel
The role of lateral lymph node dissection in the management of lower rectal cancer
verfasst von
Ziting Wang
Kep Yong Loh
Kok-Yang Tan
Emile Chung-Hou Woo
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 3/2012
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-011-0864-x

Weitere Artikel der Ausgabe 3/2012

Langenbeck's Archives of Surgery 3/2012 Zur Ausgabe

Original Article

Green tea protects human osteoblasts from cigarette smoke-induced injury: possible clinical implication

Original Article

Predictors and outcome of early recurrence after resection of hepatic metastases from colorectal cancer

Review Article

Robot-assisted prostatectomy: the new standard of care

Original Article

The impact of abdominal shape index of patients on laparoscopy-assisted distal gastrectomy for early gastric cancer

Original Article

Parathyroidectomy for the attainment of NKF-K/DOQI™ and KDIGO recommended values for bone and mineral metabolism in dialysis patients with uncontrollable secondary hyperparathyroidism

How-I-Do-It Article

Laparoscopic assisted sigmoid resection for diverticular disease

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.